WHO ICTRP trial

Exploring the Effectiveness of Synbiotics in Treating Allergic Rhinitis

CTRI/2025/01/079358 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2025/01/079358
Public title Exploring the Effectiveness of Synbiotics in Treating Allergic Rhinitis
Scientific title Unveiling the potential of symbiotics in allergic rhinitis treatment: A multi-arm double blinded randomized control trial. - NIL
Primary sponsor PES University Institute of Medical Sciences Research
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: J309- Allergic rhinitis, unspecified
Interventions Intervention1: Synbiotics: Synbiotics (Pre + Probiotics) in oral formulation for 3 months Control Intervention1: Prebiotics & Probiotics: Prebiotics in the oral formulation for 3 months Probiotics in the oral formulation for 3 months
Registration date Jan 24, 2025
Target size 165
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations